| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-08 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-08 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.17 | 1e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.15 | 1e-06 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.14 | 1e-06 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-06 |